Han Yusheng 4
Research Summary
AI-generated summary
Burning Rock Biotech (BNR) Director Han Yusheng Buys 314,870 ADS
What Happened
Han Yusheng, a director of Burning Rock Biotech Ltd (BNR), purchased 314,870 American depositary shares (ADS) on 2026-03-31 at a weighted average price of $17.36 per ADS, for a reported total of $5,466,143. This was an outright purchase (Form 4 code P), which investors often view as a more informative signal than routine sales.
Key Details
- Transaction date: 2026-03-31; Form 4 filed 2026-04-02 (appears timely).
- Reported weighted-average price: $17.36 per ADS; total value reported: $5,466,143.
- Price range: purchases occurred in multiple trades at prices between $16.10 and $18.99 (reporting person will provide breakdown on request).
- Shares purchased: 314,870 ADS. One ADS represents ten Class A ordinary shares, so this equals approximately 3,148,700 underlying ordinary shares.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Footnotes: F1 notes the 1 ADS = 10 Class A shares conversion; F2 notes the weighted-average price and multi-trade price range and that a full per-price breakdown is available upon request.
Context
- These are direct open-market purchases of ADS (not option exercises or awards).
- For retail investors, ADS purchases represent direct insider buying of the company’s underlying ordinary shares; the filing does not explain motive.
- No indication in the provided excerpt that the filing was late or that this transaction involved a 10b5-1 plan, gifts, or tax-withholding.